share_log

Argus Research Upgrades Allscripts Healthcare to Buy, Announces $26 Price Target

Argus Research Upgrades Allscripts Healthcare to Buy, Announces $26 Price Target

阿古斯研究公司將 Allscripts 醫療保健升級為購買,宣布 26 美元目標價
Benzinga Real-time News ·  2022/12/07 14:44

Argus Research analyst Jasper Hellweg upgrades Allscripts Healthcare (NASDAQ:MDRX) from Hold to Buy and announces $26 price target.

Argus Research分析師Jasper Hellweg將ALLSCRIPTS Healthcare(納斯達克:MDRX)從持有升級為買入,並宣佈26美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論